Leading Private Equity investors understand the need to generate proprietary deals.
We leverage our deep knowledge of Healthcarehealthcare sector to help clients generate proprietary deals through a process of
• Generating a comprehensive mapping of relevant companies
• Identifying potential targets that fit investor criteria
• Supporting investors in tracking/contacting identified target companies
Our rigorous methodology and ‘two set of eyes’ quality approach has enabled private equity firms to generate proprietary deals for their platform and add-on investments in following segments:
• Healthcare IT
• Physician practices including dentists, ASCs, physiotherapy, dermatology, cardiology, GPs, veterinary, behavioral health clinics
• CROs, CDMOs
• Professional service organizations in regulatory, medical communications, consulting among others
• Add-on deals in medical devices, specialty pharma

 

Client	Mid-market Private Equity firm in Western Europe
Situation	Client had recently acquired a CRO focusing on Phase 1-3 clinical trials for Pharma and Biotech customers. They were keen to augment the portfolio company’s capabilities by acquiring complementary assets in the US and also to broaden the services offering
Our approach	We leveraged our IP to generate a comprehensive database of CROs offering services that could be considered complementary to the portfolio company. Based on our research, we identified, evaluated and prioritized over 200 add-on targets and initiated contact with selected potential targets.
Results	Our client (mid-market private equity fund), managed to close 2 add-on deals for their CRO portfolio company, within a period of one year.